Spots Global Cancer Trial Database for statins
Every month we try and update this database with for statins cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation | NCT03225157 | Head and Neck N... Hearing Disorde... Hyperlipidemia | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
Quebec Lung Cancer Screening PLUS Trial | NCT05444062 | COPD Coronary Artery... | Educational mat... | 55 Years - 74 Years | McGill University Health Centre/Research Institute of the McGill University Health Centre | |
Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial | NCT02603328 | Cerebral Cavern... | Atorvastatin Placebo | 18 Years - 80 Years | University of Chicago | |
Hearing Loss and the Effects of Statin Drugs in People With Head and Neck Squamous Cell Carcinoma Treated With Cisplatin Chemoradiation | NCT03225157 | Head and Neck N... Hearing Disorde... Hyperlipidemia | 18 Years - | National Institutes of Health Clinical Center (CC) | ||
The Effect of High Dose Simvastatine on Multiple Myeloma | NCT00281476 | Multiple Myelom... | Simvastatine | 18 Years - | Vejle Hospital | |
Atorvastatin Treatment of Cavernous Angiomas With Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial | NCT02603328 | Cerebral Cavern... | Atorvastatin Placebo | 18 Years - 80 Years | University of Chicago | |
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer | NCT02201381 | Cancer Overall Surviva... | Metabolic treat... | 18 Years - 85 Years | Health Clinics Limited | |
Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer | NCT01759836 | Prostatic Neopl... | Atorvastatin 20... | - | Asan Medical Center | |
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) | NCT05483010 | Clonal Cytopeni... Myelodysplastic... | Atorvastatin Rosuvastatin | 18 Years - | Washington University School of Medicine | |
Statins in Patients With Clonal Cytopenia of Undetermined Significance (CCUS) and Myelodysplastic Syndromes (MDS) | NCT05483010 | Clonal Cytopeni... Myelodysplastic... | Atorvastatin Rosuvastatin | 18 Years - | Washington University School of Medicine | |
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer | NCT02201381 | Cancer Overall Surviva... | Metabolic treat... | 18 Years - 85 Years | Health Clinics Limited | |
Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer | NCT01759836 | Prostatic Neopl... | Atorvastatin 20... | - | Asan Medical Center | |
Study of the Safety, Tolerability and Efficacy of Metabolic Combination Treatments on Cancer | NCT02201381 | Cancer Overall Surviva... | Metabolic treat... | 18 Years - 85 Years | Health Clinics Limited | |
Quebec Lung Cancer Screening PLUS Trial | NCT05444062 | COPD Coronary Artery... | Educational mat... | 55 Years - 74 Years | McGill University Health Centre/Research Institute of the McGill University Health Centre |